Christopher Boerner
Patrimonio netto: 9 M $ in data 30/06/2026
Patrimonio netto: 9 M $ in data 30/06/2026
Christopher S.
Boerner is Chairman & Chief Executive Officer at Bristol Myers Squibb Co. since 2024 and holds the same titles at The Bristol-Myers Squibb Canada Co. He is Director at Capital Health System, Inc. and Pharmaceutical Research & Manufacturers of America.
Starting in 2026, Dr. Boerner will be Independent Director at Colgate-Palmolive Co. Formerly, Dr. Boerner was Marketing Director at Genentech, Inc. in 2010, Independent Director at Achaogen, Inc. from 2014 to 2015, Vice President-Marketing at Dendreon Corp.
in 2010, Executive Vice President-Commercial at Seagen, Inc. from 2014 to 2015, and Associate at McKinsey & Co., Inc. Education includes undergraduate studies at Washington University in St. Louis and graduate and doctorate degrees from Haas School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/03/2026 | 146.890 ( 0,01% ) | 8 M $ | 30/06/2026 | |
| 11/05/2026 | 1.383 ( 0% ) | 126 793 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Amministratore Delegato | 01/11/2023 |
| COLGATE-PALMOLIVE COMPANY | Direttore/Membro del Consiglio | 15/03/2026 |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Direttore/Membro del Consiglio | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | - |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| ACHAOGEN | Direttore/Membro del Consiglio | 10/06/2015 |
| SEAGEN INC. | Corporate Officer/Principal | 30/01/2015 |
| DENDREON CORPORATION | Vendite & Marketing | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Vendite & Marketing | 01/01/2010 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Colgate-Palmolive Co.
Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale